OQROGet OQRO Pro
Insider trade

Labcorp (LH)CEO sold ~$1.51M

Adam H Schechter, CEO at Labcorp, sold ~$1.51M of Labcorp shares.

~$1.51M
Approx. value · 5,745 sh @ $262.75
88K
Holds after · shares reported
Traded
Nov 11, 2025
Filed
Nov 13, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 28, 2025Company filing · Form 8-K · ResultsReported its results
  2. Oct 29, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  3. Oct 31, 2025InsiderDirector sold ~$1.78M of LH shares in the open market
  4. Oct 31, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  5. Nov 11, 2025 · this disclosureInsiderCEO sold ~$1.51M of LH shares in the open market

What came next

  1. Nov 17, 2025CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  2. Nov 20, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Labcorp Holdings Inc. (the “Company”) today announced that on November 20, 2025, the Company’s Board of Directors (the “Board”) appointed Victor Bulto as a member of the Board, effective December 1, 2025.”
  3. Dec 5, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On December 5, 2025, Dr. D. Gary Gilliland notified the Board of Directors (the “Board”) of Labcorp Holdings Inc. (the “Company”) of his decision to retire from the Board, effective December 31, 2025.”
  4. Dec 9, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 9, 2025, Mark Schroeder, the Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer of Labcorp Holdings Inc. (the “Company”), notified the Company of his intention to retire, effective on April 1, 2026.”
  5. Jan 28, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  6. Jan 28, 2026CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  7. Feb 4, 2026CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  8. Feb 6, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Labcorp Holdings Inc. (the “Company”) today announced that on February 6, 2026, the Company’s Board of Directors (the “Board”) appointed John H. Sampson, M.D., Ph.D., as a member of the Board, effective February 9, 2026.”
  9. Feb 9, 2026InsiderOfficer sold ~$24K of LH shares in the open market
  10. Feb 10, 2026InsiderOfficer sold ~$25K of LH shares in the open market
  11. Feb 11, 2026InsiderCEO sold ~$1.5M of LH shares in the open market
  12. Feb 11, 2026CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  13. Feb 12, 2026InsiderOfficer sold ~$25K of LH shares in the open market
  14. Feb 17, 2026Company filing · Form 8-K · ResultsReported its results
  15. Feb 19, 2026InsiderOfficer sold ~$185K of LH shares in the open market
  16. Feb 24, 2026InsiderOfficer sold ~$429K of LH shares in the open market
  17. Feb 27, 2026InsiderOfficer sold ~$156K of LH shares in the open market
  18. Mar 3, 2026Insider · Their largest sale since 2018CEO sold ~$2.44M of LH shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Labcorp

For Labcorp, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports and 13 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LH page.

Other recent filings by Adam H Schechter, President & CEO

The full history of Adam H Schechter, President & CEO is on the profile page.

How this filing works

Other disclosures at Labcorp

Everything OQRO holds on this company is on its LH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data